177 related articles for article (PubMed ID: 23826570)
21. Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
Dietrich S; Hüllein J; Hundemer M; Lehners N; Jethwa A; Capper D; Acker T; Garvalov BK; Andrulis M; Blume C; Schulte C; Mandel T; Meissner J; Fröhling S; von Kalle C; Glimm H; Ho AD; Zenz T
J Clin Oncol; 2013 Jul; 31(19):e300-3. PubMed ID: 23690412
[No Abstract] [Full Text] [Related]
22. Pyrosequencing of BRAF V600E in routine samples of hairy cell leukaemia identifies CD5+ variant hairy cell leukaemia that lacks V600E.
Lennerz JK; Klaus BM; Marienfeld RB; Möller P
Br J Haematol; 2012 Apr; 157(2):267-9. PubMed ID: 22145942
[No Abstract] [Full Text] [Related]
23. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.
Raess PW; Mintzer D; Husson M; Nakashima MO; Morrissette JJ; Daber R; Bagg A
Blood; 2013 Oct; 122(17):3084-5. PubMed ID: 24159168
[No Abstract] [Full Text] [Related]
24. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
[TBL] [Abstract][Full Text] [Related]
25.
Bibi A; Java S; Chaudhary S; Joshi S; Mascerhenas R; Rabade N; Tembhare P; Subramanian PG; Gujral S; Menon H; Khattry N; Sengar M; Bagal B; Jain H; Patkar N
Indian J Pathol Microbiol; 2018; 61(4):532-536. PubMed ID: 30303143
[TBL] [Abstract][Full Text] [Related]
26. Hairy cell leukaemia with unusual BRAF mutations.
Maitre E; Macro M; Troussard X
J Cell Mol Med; 2023 Sep; 27(17):2626-2630. PubMed ID: 37530550
[TBL] [Abstract][Full Text] [Related]
27. Real-world experience of
Langabeer SE; O'Brien D; McCarron S; Bacon CL; Vandenberghe E
J Clin Pathol; 2021 Dec; 74(12):819. PubMed ID: 33372104
[No Abstract] [Full Text] [Related]
28. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
Tiacci E; Schiavoni G; Martelli MP; Boveri E; Pacini R; Tabarrini A; Zibellini S; Santi A; Pettirossi V; Fortini E; Ascani S; Arcaini L; Inghirami G; Paulli M; Falini B
Haematologica; 2013 Apr; 98(4):635-9. PubMed ID: 23349307
[TBL] [Abstract][Full Text] [Related]
29. Atypical presentation of hairy cell leukemia: Significance of CD200 on flow cytometry.
Rahman K; Kumari S; Singh MK; Gupta R; Yadav G; Kumari N; Nityan S
J Cancer Res Ther; 2018; 14(5):1130-1134. PubMed ID: 30197362
[TBL] [Abstract][Full Text] [Related]
30. Hairy cell leukemia: Past, present and future.
Getta BM; Park JH; Tallman MS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):269-72. PubMed ID: 26614906
[TBL] [Abstract][Full Text] [Related]
31. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.
Brown NA; Weigelin HC; Bailey N; Laliberte J; Elenitoba-Johnson KS; Lim MS; Betz BL
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):590-600. PubMed ID: 24503706
[TBL] [Abstract][Full Text] [Related]
32. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.
Tiacci E; Schiavoni G; Forconi F; Santi A; Trentin L; Ambrosetti A; Cecchini D; Sozzi E; Francia di Celle P; Di Bello C; Pulsoni A; Foà R; Inghirami G; Falini B
Blood; 2012 Jan; 119(1):192-5. PubMed ID: 22028477
[TBL] [Abstract][Full Text] [Related]
33. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
[TBL] [Abstract][Full Text] [Related]
34. Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of
Soong D; Kumar P; Jatwani K; Park J; Dogan A; Taylor J
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250418
[No Abstract] [Full Text] [Related]
35. Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.
Blachly JS; Lozanski G; Lucas DM; Grever MR; Kendra K; Andritsos LA
J Natl Compr Canc Netw; 2015 Jan; 13(1):9-13; quiz 13. PubMed ID: 25583765
[TBL] [Abstract][Full Text] [Related]
36. Test and teach. Number one hundred and one: Part 1.
Westerman DA; Juneja SK
Pathology; 2000 May; 32(2):118, 137-8. PubMed ID: 10840832
[No Abstract] [Full Text] [Related]
37. [Hairy cell leukemia].
Dietrich S; Zenz T
Dtsch Med Wochenschr; 2015 Jun; 140(12):882-4. PubMed ID: 26069911
[No Abstract] [Full Text] [Related]
38. Inhibitor of BRAF
Smirnova SY; Al-Radi LS; Moiseeva TN; Gemdzhian EG; Yakutik IA; Julhakyan HL; Novikov VA; Galstyan GM; Sudarikov AB
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):427-430. PubMed ID: 33811006
[TBL] [Abstract][Full Text] [Related]
39. Hairy Cell Leukemia with Systemic Lymphadenopathy: Detection of BRAF Mutations in Both Lymph Node and Peripheral Blood Specimens.
Okada K; Kunitomi A; Sakai K; Muranushi H; Okamoto Y; Tsukamoto T; Sugiura H; Matsui H; Jo T; Ueda T; Onishi T; Ide M; Kimura S; Notohara K; Ueda Y
Intern Med; 2015; 54(11):1397-402. PubMed ID: 26027995
[TBL] [Abstract][Full Text] [Related]
40. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias.
Tschernitz S; Flossbach L; Bonengel M; Roth S; Rosenwald A; Geissinger E
Br J Haematol; 2014 May; 165(4):529-33. PubMed ID: 24433452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
